John E. Godwin

6.6k citations
109 papers · 5.3k · 3 hit papers · h-index 32

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 58
    • Chronic Myeloid Leukemia Treatments 12
    • Hematopoietic Stem Cell Transplantation 9
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 13

John E. Godwin

106 papers receiving 5.0k citations

John E. Godwin's Hit Papers

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study 2022 · 192 citations
1920+9+19Years since publication2505007501000

Peers

John E. Godwin
Comparison fields: 5 of 122
  • Hematology 3.1k
  • Genetics 811
  • Oncology 1.5k
  • Public Health, Environmental and Occupational Health 893
  • Molecular Biology 1.8k
Replace Pierre W. Wijermans with:
Pierre W. Wijermans Netherlands
R Ohno Japan
Utz O. Krug Germany
Eric Jay Feldman United States
Ralph Wäsch Germany
Stephen Anthony Strickland United States
Kristina M. Laumann United States
José Cervera Spain
Daniela Cilloni Italy
Sophie Park France
John E. Godwin relative to Pierre W. Wijermans Netherlands Pierre W. Wijermans's profile →
Citations per field
00.5×1.7×
Pierre W. Wijermans · 1×
Citations per year

Countries citing papers authored by John E. Godwin

Since Specialization
Citations

This map shows the geographic impact of John E. Godwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Godwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Godwin more than expected).

Fields of papers citing papers by John E. Godwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Godwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Godwin. The network helps show where John E. Godwin may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Godwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Godwin Line = papers co-authored together John E. Godwin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Age and acute myeloid leukemia
Hit paper breakdown →
20061133
2
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
Hit paper breakdown →
1997757
3 1998272
4 2020263
5 1995209
6 1980194
7
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study
Hit paper breakdown →
2022192
8 2004145
9 2013137
10 2015124
11 2020119
12 1996100
13 198881
14 201365
15 202063
16
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.
199359
17 200959
18 200858
19 200854
20 200153

About John E. Godwin

John E. Godwin is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 109 papers that have together received 5.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (58 papers), Acute Lymphoblastic Leukemia research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), CAR-T cell therapy research (12 papers), Chronic Myeloid Leukemia Treatments (12 papers), Lymphoma Diagnosis and Treatment (12 papers), Neutropenia and Cancer Infections (9 papers) and Hematopoietic Stem Cell Transplantation (9 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (811 citations), Oncology (1.5k citations), Public Health, Environmental and Occupational Health (893 citations) and Molecular Biology (1.8k citations). John E. Godwin has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Frederick R. Appelbaum, Cheryl L. Willman, David R. Head, Marilyn L. Slovak, Stephen H. Petersdorf, Jeanne E. Anderson, Kenneth Joseph Kopecky, Holly M. Gundacker, Catherine P. Leith and Sucha Nand. Their work appears in journals such as Blood, Leukemia, American Journal of Hematology, Blood Advances and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact